Project Number 3U19AG010483-26S8 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Alzheimer's Disease Cooperative Study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category G. Consortia and Public Private Partnerships 1. Consortia Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development Researcher and Organization Principal Investigator FELDMAN, HOWARD Principal Investigator First Name HOWARD Principal Investigator Last Name FELDMAN Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-001: Limited Competition: Alzheimer's Disease Cooperative Study (U19) FY Overall Cost $8,741,293 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MCLINDEN, KRISTINA Related Resources Repository [AlzPED] CRF receptor-1 antagonism mitigates Aβ pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease [AlzPED] Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. [AMP-AD Knowledge Portal] Alzheimer’s Disease Cooperative Study (ADCS) Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial (A4 Trial) Clinical Trial Prazosin for Agitation in Alzheimer's Disease Exercise in Adults With Mild Memory Problems Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
